7 Overordnet var CHMP enig i, at der foreligger et positivt benefit/ risk- forhold for moxifloxacin til indikationen for PID over en periode på 14 dage.
Overall, the CHMP agreed that the benefit/ risk balance of moxifloxacin in the PID indication over 14 days is positive.